Rigel to drop skin disease drug after trial failure

(Reuters) - Rigel Pharmaceuticals Inc said it would stop the development of its drug to treat skin lesions in patients with discoid lupus, a chronic skin disease, after the treatment failed a mid-stage trial.

Source: Reuters: Health - October 24, 2013 Category: Consumer Health News Tags: healthNews Source Type: news